February 14, 2020 / 1:19 PM / 8 days ago

BRIEF-InMed Pharmaceuticals Posts Quarterly Loss Per Share Of C$0.02

Feb 14 (Reuters) - InMed Pharmaceuticals Inc:

* INMED PHARMACEUTICALS REPORTS SECOND QUARTER FISCAL 2020 FINANCIAL RESULTS AND PROVIDES RESEARCH AND DEVELOPMENT AND BUSINESS UPDATE

* Q2 LOSS PER SHARE C$0.02

* ANTICIPATE FILING A CTA FOR A SECOND PHASE 1 TRIAL, 755-102-HV, IN CURRENT CALENDAR QUARTER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below